首页> 外国专利> ENTEROCOCCUS FAECALIS HAVING RESISTANCE TO CEPHALOSPORIN AND HIGH EXPRESSION OF SIRTUIN 2-LIKE PROTEIN AND USE THEREOF

ENTEROCOCCUS FAECALIS HAVING RESISTANCE TO CEPHALOSPORIN AND HIGH EXPRESSION OF SIRTUIN 2-LIKE PROTEIN AND USE THEREOF

机译:肠球菌粪便对头孢菌素具有抗性,并且Sirtuin 2-like蛋白的高表达及其用途

摘要

Provided are an Enterococcus faecalis having resistance to cephalosporin and high expression of sirtuin 2-like protein and the use thereof. The Enterococcus faecalis EF23 having resistance to cephalosporin and high expression of Sir2-like protein is deposited in the Preservation Center of Wuhan University, China Center for Type Culture Collection under the deposit number of CCTCC NO: M 2018012, the deposit address being Luojiashan, Wuchang, Wuhan City, Hubei Province, and the deposit date being 8 January 2018. Through the experiment it has been found that the Enterococcus faecalis EF23 having resistance to cephalosporin and high expression of Sir2-like protein can enhance aerobic oxidation of glucose in cells, increase mitochondrial respiration, and regulate ATP energy metabolic pathways, thereby realizing the treatment of various metabolism-related diseases, such as cell senescence, mitochondrial dysfunction and metabolic syndrome.
机译:本发明提供了对头孢菌素具有抗性和sirtuin 2样蛋白的高表达的粪肠球菌及其用途。具有抗头孢菌素和Sir2样蛋白高表达能力的粪肠球菌EF23保藏中心为武汉市中国典型培养物保藏中心,保藏编号为CCTCC NO:M 2018012,保藏地址为武昌chang家山。位于湖北省武汉市,保藏日期为2018年1月8日。通过实验发现,对头孢菌素具有抗性和Sir2类蛋白高表达的粪肠球菌EF23可以增强细胞中葡萄糖的需氧氧化,增加线粒体的呼吸作用,调节ATP能量代谢途径,从而实现对各种与代谢有关的疾病的治疗,例如细胞衰老,线粒体功能障碍和代谢综合征。

著录项

  • 公开/公告号WO2020082220A1

    专利类型

  • 公开/公告日2020-04-30

    原文格式PDF

  • 申请/专利权人 LI SHIYU;

    申请/专利号WO2018CN111319

  • 申请日2018-10-23

  • 分类号C12N1/20;A61K35/744;A61P39/06;A23L33/135;A23L33/195;

  • 国家 WO

  • 入库时间 2022-08-21 11:11:39

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号